Montes Archimedes Acquisition (ROIV)
(Delayed Data from NSDQ)
$11.65 USD
+0.02 (0.17%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $11.42 -0.23 (-1.97%) 6:12 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Roivant Sciences Ltd.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ROIV 11.65 +0.02(0.17%)
Will ROIV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ROIV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ROIV
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates
Should Invesco S&P MidCap 400 GARP ETF (GRPM) Be on Your Investing Radar?
ROIV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Lags Revenue Estimates
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
Codexis (CDXS) Reports Q1 Loss, Misses Revenue Estimates
Other News for ROIV
Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide ...
Roivant Sciences (ROIV) Anticipated to Benefit from Brepocitinib Developments | ROIV Stock News
Roivant Sciences placed on 'Positive Catalyst Watch' at JPMorgan
What Does the Market Think About Roivant Sciences?
See How Roivant Sciences Ranks Among Analysts' Top Picks With Strong Buyback Activity